XOMA Royalty (XOMA) EBT Margin (2011 - 2026)
XOMA Royalty's (XOMA) quarterly EBT Margin came in at 36.26% in Q1 2026, down 2292.0% year-on-year from 1.65% in Q1 2025, and up 160.11% quarter-over-quarter from 60.32% in Q4 2025.
XOMA Royalty (XOMA) EBT Margin (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed EBT Margin across 16 years of filings, most recently posting 36.26% for Q1 2026.
- EBT Margin for Q1 2026 came in at 36.26%, down 2292.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.83% (up 18464.0% YoY), and the FY2025 annual result was 0.42%, down 18.0% from the prior year.
- EBT Margin came in at 36.26% for Q1 2026 at XOMA Royalty, up from 60.32% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 6266.67% in Q3 2025 to a low of 68972.0% in Q3 2024.
- The 5-year median for EBT Margin is 417.9% (2022), against an average of 4034.07%.
- Across the five-year window, EBT Margin tumbled 6827477 bps in 2024 and jumped 7523867 bps in 2025, its largest moves.
- XOMA Royalty's EBT Margin stood at 417.9% in 2022, then sank by 160 bps to 1087.51% in 2023, then jumped by 280 bps to 1957.0% in 2024, then tumbled by 103 bps to 60.32% in 2025, then surged by 160 bps to 36.26% in 2026.
- The last three EBT Margin figures came in at 36.26% (Q1 2026), 60.32% (Q4 2025), and 6266.67% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 6.40% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 36.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.26% |
| Dec 31, 2025 | -60.32% |
| Sep 30, 2025 | 6,266.67% |
| Jun 30, 2025 | 27.20% |
| Mar 31, 2025 | 59.18% |
| Dec 31, 2024 | 1,957.00% |
| Sep 30, 2024 | -68,972.00% |
| Jun 30, 2024 | -268.28% |
| Mar 31, 2024 | -708.39% |
| Dec 31, 2023 | -1,087.51% |
| Sep 30, 2023 | -697.23% |
| Jun 30, 2023 | -865.84% |
| Mar 31, 2023 | -2,327.23% |
| Dec 31, 2022 | -417.90% |
| Sep 30, 2022 | -969.40% |
| Jun 30, 2022 | -484.94% |
| Mar 31, 2022 | -66.46% |
| Dec 31, 2021 | 14,973.00% |
| Sep 30, 2021 | -471.91% |
| Jun 30, 2021 | -248.28% |